$PZG
Paramount Gold Nevada Corp Stock $pzg

$pzg Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000095017024109633 Filed on September 26, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue		$120.5K	$2.512M
YoY Change		33.9%	1295.37%
Cost Of Revenue		$176.1K	$647.5K
YoY Change		10.04%	2.78%
Gross Profit		-$55.56K	$1.864M
YoY Change		-20.63%	-514.26%
Gross Profit Margin		-46.1%	74.22%
Selling, General & Admin		$700.2K	$2.732M
YoY Change		25.03%	7.97%
% of Gross Profit			146.54%
Research & Development		-$1.938M	$2.062M
YoY Change		-380.88%	-20.71%
% of Gross Profit			110.59%
Depreciation & Amortization	$1.442K	$340.00	$1.358K
YoY Change	321.64%		-29.78%
% of Gross Profit			0.07%
Operating Expenses	$1.405M	$1.479M	$8.489M
YoY Change	-30.63%	8.71%	36.71%
Operating Profit	-$1.405M	-$1.534M	-$8.489M
YoY Change	-30.63%	7.28%	36.71%
Interest Expense		-$1.026M	-$2.046M
YoY Change		689.38%	344.76%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		-$2.560M	-$8.023M
YoY Change		63.07%	23.66%
Income Tax		$33.41K	$33.41K
% Of Pretax Income
Net Earnings	-$1.572M	-$2.594M	-$8.056M
YoY Change	-24.2%	69.52%	24.9%
Net Earnings / Revenue		-2152.25%	-320.76%
Basic Earnings Per Share	-$0.02		-$0.13
Diluted Earnings Per Share	-$0.02	-$0.04	-$0.13
COMMON SHARES
Basic Shares Outstanding	65.16M	63.63M	59.89M
Diluted Shares Outstanding	65.17M		59.89M

Balance Sheet

Concept	2024 Q3	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments		$5.423M	$5.423M
YoY Change		561.35%	561.35%
Cash & Equivalents	$4.294M	$5.423M	$5.423M
Short-Term Investments
Other Short-Term Assets		$1.320M	$1.320M
YoY Change		-10.22%	-10.22%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$5.347M	$6.743M	$6.743M
YoY Change	113.73%	193.52%	193.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.800K	$3.221K	$49.07M
YoY Change	131.3%	-29.66%	-4.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$546.2K	$546.2K
YoY Change		-0.69%	-0.69%
Total Long-Term Assets	$49.63M	$49.62M	$49.62M
YoY Change	-4.58%	-4.6%	-4.6%
TOTAL ASSETS
Total Short-Term Assets	$5.347M	$6.743M	$6.743M
Total Long-Term Assets	$49.63M	$49.62M	$49.62M
Total Assets	$54.97M	$56.36M	$56.36M
YoY Change	0.85%	3.78%	3.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$563.8K	$563.8K
YoY Change		-40.02%	-40.02%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$509.2K	$683.8K	$683.8K
YoY Change	-95.02%	-92.69%	-92.69%
LONG-TERM LIABILITIES
Long-Term Debt		$15.10M	$15.10M
YoY Change
Other Long-Term Liabilities		$2.150M	$2.150M
YoY Change		14.38%	14.38%
Total Long-Term Liabilities	$17.39M	$17.52M	$17.25M
YoY Change	691.46%	727.92%	817.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$509.2K	$683.8K	$683.8K
Total Long-Term Liabilities	$17.39M	$17.52M	$17.25M
Total Liabilities	$17.90M	$18.21M	$18.21M
YoY Change	43.99%	58.78%	58.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$83.95M	-$82.38M
YoY Change	9.89%	10.84%
Common Stock	$121.0M	$120.5M
YoY Change	2.15%	2.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$37.08M	$38.16M	$38.16M
YoY Change
Total Liabilities & Shareholders Equity	$54.97M	$56.36M	$56.36M
YoY Change	0.85%	3.78%	3.78%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	-$1.572M	-$2.594M	-$8.056M
YoY Change	-24.2%	69.52%	24.9%
Depreciation, Depletion And Amortization	$1.442K	$340.00	$1.358K
YoY Change	321.64%		-29.78%
Cash From Operating Activities	-$1.167M	-$2.345M	-$5.409M
YoY Change	29.82%	19.62%	2.99%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$100.0K
YoY Change			25.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$8.021K	$0.00	-$100.0K
YoY Change		-100.0%	-21.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.923M
YoY Change			-13.37%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	46.36K	755.2K	10.11M
YoY Change	-95.74%	-66.43%	171.72%
NET CHANGE
Cash From Operating Activities	-1.167M	-2.345M	-5.409M
Cash From Investing Activities	-8.021K	0.000	-100.0K
Cash From Financing Activities	46.36K	755.2K	10.11M
Net Change In Cash	-1.129M	-1.589M	4.598M
YoY Change	-696.76%	-762.21%	-377.12%
FREE CASH FLOW
Cash From Operating Activities	-$1.167M	-$2.345M	-$5.409M
Capital Expenditures		$0.00	$100.0K
Free Cash Flow		-$2.345M	-$5.509M
YoY Change		19.62%	3.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001629210
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q2	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024	pzg	Increase Decrease In Reclamation Bonds Accounts IncreaseDecreaseInReclamationBondsAccounts
CY2024	pzg	Payments To Acquire Reclamation Bond PaymentsToAcquireReclamationBond
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt
CY2024	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable
CY2024	us-gaap	Income Tax Examination Year Under Examination IncomeTaxExaminationYearUnderExamination	2019 2020 2021 2022 2023
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-36908
CY2024	dei	Entity Registrant Name EntityRegistrantName	PARAMOUNT GOLD NEVADA CORP.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0138393
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	665 Anderson Street
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Winnemucca
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89445
CY2024	dei	City Area Code CityAreaCode	775
CY2024	dei	Local Phone Number LocalPhoneNumber	625-3600
CY2024	dei	Security12b Title Security12bTitle	Common Stock
CY2024	dei	Trading Symbol TradingSymbol	PZG
CY2024	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	17349313
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	65159223
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	dei	Auditor Name AuditorName	Moss Adams LLP
CY2024	dei	Auditor Firm AuditorFirmId	659
CY2024	dei	Auditor Firm AuditorFirmId	659
CY2024	dei	Auditor Name AuditorName	Moss Adams LLP
CY2024	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5423059
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	824920
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1319743
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1472286
CY2024Q2	us-gaap	Assets Current AssetsCurrent	6742802
CY2023Q2	us-gaap	Assets Current AssetsCurrent	2297206
CY2024Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	49069413
CY2023Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	51458261
CY2024Q2	pzg	Reclamation Bond Noncurrent ReclamationBondNoncurrent	546176
CY2023Q2	pzg	Reclamation Bond Noncurrent ReclamationBondNoncurrent	546176
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3221
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4579
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	49618810
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	52009016
CY2024Q2	us-gaap	Assets Assets	56361612
CY2023Q2	us-gaap	Assets Assets	54306222
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	563806
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	937219
CY2024Q2	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	120000
CY2023Q2	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	2560515
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	3614465
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	658363
CY2023Q2	pzg	Notes Payable Related Parties NotesPayableRelatedParties	1579397
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	683806
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9349959
CY2024Q2	pzg	Net Debt Liability Of Royalty Convertible Debenture NetDebtLiabilityOfRoyaltyConvertibleDebenture	11456523
CY2024Q2	pzg	Derivative Liability Of Royalty Convertible Debenture DerivativeLiabilityOfRoyaltyConvertibleDebenture	3642105
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	273450
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	240043
CY2024Q2	us-gaap	Mine Reclamation And Closing Liability Noncurrent MineReclamationAndClosingLiabilityNoncurrent	2150288
CY2023Q2	us-gaap	Mine Reclamation And Closing Liability Noncurrent MineReclamationAndClosingLiabilityNoncurrent	1876387
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	17522366
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2116430
CY2024Q2	us-gaap	Liabilities Liabilities	18206172
CY2023Q2	us-gaap	Liabilities Liabilities	11466389
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65044305
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65044305
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54812248
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54812248
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	650444
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	548124
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	119883235
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	116613503
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-82378239
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74321794
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	38155440
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	42839833
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56361612
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54306222
CY2024	pzg	Exploration And Development Expenses ExplorationAndDevelopmentExpenses	2061618
CY2023	pzg	Exploration And Development Expenses ExplorationAndDevelopmentExpenses	2423556
CY2024	pzg	Reclamation Expenses ReclamationExpenses	2605799
CY2023	pzg	Reclamation Expenses ReclamationExpenses	172153
CY2024	pzg	Land Holding Costs LandHoldingCosts	647497
CY2023	pzg	Land Holding Costs LandHoldingCosts	632484
CY2024	us-gaap	Professional Fees ProfessionalFees	337628
CY2023	us-gaap	Professional Fees ProfessionalFees	377822
CY2024	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1505912
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1238895
CY2024	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	199590
CY2023	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	143192
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	688537
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	774817
CY2024	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	442234
CY2023	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	446245
CY2024	us-gaap	Operating Expenses OperatingExpenses	8488815
CY2023	us-gaap	Operating Expenses OperatingExpenses	6209164
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-8488815
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-6209164
CY2024	us-gaap	Other Income OtherIncome	2511660
CY2023	us-gaap	Other Income OtherIncome	184059
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-881727
CY2024	pzg	Interest And Service Charges InterestAndServiceCharges	1164156
CY2023	pzg	Interest And Service Charges InterestAndServiceCharges	463010
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8023038
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6488115
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	33407
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-37584
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-8056445
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6450531
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59891837
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59891837
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48695858
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48695858
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	42839833
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	331095
CY2024	pzg	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	1923120
CY2024	pzg	Stock Issued During Period Value Payment Of Interest Accrued StockIssuedDuringPeriodValuePaymentOfInterestAccrued	1117837
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-8056445
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	38155440
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	46399750
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	349992
CY2023	pzg	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	2219796
CY2023	pzg	Stock Issued During Period Value Payment Of Interest Accrued StockIssuedDuringPeriodValuePaymentOfInterestAccrued	320826
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6450531
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	42839833
CY2024	us-gaap	Profit Loss ProfitLoss	-8056445
CY2023	us-gaap	Profit Loss ProfitLoss	-6450531
CY2024	us-gaap	Depreciation Depreciation	1358
CY2023	us-gaap	Depreciation Depreciation	1934
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	331095
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	349992
CY2024	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	91874
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	51018
CY2024	us-gaap	Paid In Kind Interest PaidInKindInterest	964069
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	240702
CY2024	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	442234
CY2023	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	446245
CY2024	us-gaap	Asset Retirement Obligation Cash Paid To Settle AssetRetirementObligationCashPaidToSettle	120000
CY2023	us-gaap	Asset Retirement Obligation Cash Paid To Settle AssetRetirementObligationCashPaidToSettle	120001
CY2023	pzg	Increase Decrease In Reclamation Bonds Accounts IncreaseDecreaseInReclamationBondsAccounts	1200
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-881727
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	33407
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-37584
CY2024	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-152543
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	191391
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-131209
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	458484
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5409347
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5252332
CY2023	pzg	Payments To Acquire Reclamation Bond PaymentsToAcquireReclamationBond	46700
CY2024	pzg	Payment To Acquire Mineral Properties PaymentToAcquireMineralProperties	100000
CY2023	pzg	Payment To Acquire Mineral Properties PaymentToAcquireMineralProperties	80000
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-100000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-126700
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1923120
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2219796
CY2024	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	15000000
CY2024	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	870111
CY2024	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	4277690
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1500000
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1667833
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10107486
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3719796
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4598139
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1659236
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	824920
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2484156
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5423059
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	824920
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant estimates made by management in the accompanying consolidated financial statements include the adequacy of the Company’s reclamation and environmental obligation, share based compensation, valuation of deferred tax asset, and assessment of impairment of mineral properties.</span></p>
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and cash equivalents. The Company maintains cash in accounts which may, at times, exceed federally insured limits. At June 30, 2024 and 2023, the Company had $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, of balances in excess of federally insured limits. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company deposits its cash with financial institutions which it believes have sufficient credit quality to minimize the risk of loss</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p>
CY2024Q2	pzg	Concentration Of Credit Risk Uninsured Cash Amount ConcentrationOfCreditRiskUninsuredCashAmount	5200000
CY2023Q2	pzg	Concentration Of Credit Risk Uninsured Cash Amount ConcentrationOfCreditRiskUninsuredCashAmount	600000
CY2024	pzg	Cash Uninsured Amount Description CashUninsuredAmountDescription	The Company deposits its cash with financial institutions which it believes have sufficient credit quality to minimize the risk of loss
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5423059
CY2023Q4	pzg	Proceeds From Debenture ProceedsFromDebenture	15000000
CY2024	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	8369602
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-881727
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	709500
CY2024	pzg	Fair Value Of Shares Issued For Equity Compensation Plans FairValueOfSharesIssuedForEquityCompensationPlans	254688
CY2024	us-gaap	Insurance Recoveries InsuranceRecoveries	2501780
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	425500
CY2023	pzg	Fair Value Of Shares Issued For Equity Compensation Plans FairValueOfSharesIssuedForEquityCompensationPlans	142650
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3142803
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	709500
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	425500
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	331095
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	349992
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	657333
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.55
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.19
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	95002
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.41
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	153995
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.82
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	458336
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.47
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	458336
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.47
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3275
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	8174
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y10M6D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	26552
CY2024Q2	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	3642105
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	2760378
CY2024Q2	pzg	Debt Liability Of Royalty Convertible Debenture Before Issuance Costs DebtLiabilityOfRoyaltyConvertibleDebentureBeforeIssuanceCosts	12239622
CY2023Q4	pzg	Debt Liability Of Royalty Convertible Debenture Before Issuance Costs DebtLiabilityOfRoyaltyConvertibleDebentureBeforeIssuanceCosts	12239622
CY2024Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	783099
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	870111
CY2024Q2	pzg	Net Debt Liability Of Royalty Convertible Debenture NetDebtLiabilityOfRoyaltyConvertibleDebenture	11456523
CY2023Q4	pzg	Net Debt Liability Of Royalty Convertible Debenture NetDebtLiabilityOfRoyaltyConvertibleDebenture	11369511
CY2024Q2	pzg	Derivative Liability Of Royalty Convertible Debenture DerivativeLiabilityOfRoyaltyConvertibleDebenture	3642105
CY2023Q4	pzg	Derivative Liability Of Royalty Convertible Debenture DerivativeLiabilityOfRoyaltyConvertibleDebenture	2760378
CY2024Q2	us-gaap	Convertible Debt ConvertibleDebt	15098628
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	14129889
CY2024Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	49069413
CY2023Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	51458261
CY2024Q2	pzg	Reclamation Bond Noncurrent ReclamationBondNoncurrent	546176
CY2023Q2	pzg	Reclamation Bond Noncurrent ReclamationBondNoncurrent	546176
CY2024	us-gaap	Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate	0.0993
CY2023	us-gaap	Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate	0.0993
CY2024	pzg	Weighted Average Inflation Rate WeightedAverageInflationRate	0.0253
CY2023	pzg	Weighted Average Inflation Rate WeightedAverageInflationRate	0.0249
CY2023Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	4436902
CY2022Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	4475270
CY2024	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	442234
CY2023	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	446245
CY2024	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	-84295
CY2023	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	-364612
CY2024	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	2524553
CY2023	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	120001
CY2024Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2270288
CY2023Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	4436902
CY2024	pzg	Changes In Estimates And Settlements For Reclamation And Environmental Obligation ChangesInEstimatesAndSettlementsForReclamationAndEnvironmentalObligation	2608848
CY2023	pzg	Changes In Estimates And Settlements For Reclamation And Environmental Obligation ChangesInEstimatesAndSettlementsForReclamationAndEnvironmentalObligation	484613
CY2024Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2270288
CY2023Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	4436902
CY2024Q2	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	120000
CY2023Q2	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	2560515
CY2024Q2	us-gaap	Mine Reclamation And Closing Liability Noncurrent MineReclamationAndClosingLiabilityNoncurrent	2150288
CY2023Q2	us-gaap	Mine Reclamation And Closing Liability Noncurrent MineReclamationAndClosingLiabilityNoncurrent	1876387
CY2024	us-gaap	Insurance Recoveries InsuranceRecoveries	2501780
CY2023	us-gaap	Insurance Recoveries InsuranceRecoveries	178084
CY2024	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	6095
CY2023	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5975
CY2024	pzg	Restitution Payment RestitutionPayment	3785
CY2024	us-gaap	Other Income OtherIncome	2511660
CY2023	us-gaap	Other Income OtherIncome	184059
CY2024	pzg	Exploration And Development Expenses ExplorationAndDevelopmentExpenses	2061618
CY2024	pzg	Reclamation Expenses ReclamationExpenses	2605799
CY2024	pzg	Land Holding Costs LandHoldingCosts	647497
CY2023	pzg	Exploration And Development Expenses ExplorationAndDevelopmentExpenses	2423556
CY2023	pzg	Reclamation Expenses ReclamationExpenses	172153
CY2023	pzg	Land Holding Costs LandHoldingCosts	632484
CY2024Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	49069413
CY2023Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	51458261
CY2024Q2	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	35736884
CY2023Q2	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	30375155
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8023038
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6488115
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1684838
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1362504
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1099
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	309
CY2024	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-67181
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-4249
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1784327
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1328860
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33407
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-37584
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	33407
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-37584

Files In Submission

Name	View Source	Status
0000950170-24-109633-index-headers.html	Edgar Link	pending
0000950170-24-109633-index.html	Edgar Link	pending
0000950170-24-109633.txt	Edgar Link	pending
0000950170-24-109633-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img162867219_0.jpg	Edgar Link	pending
img162867219_1.jpg	Edgar Link	pending
img162867219_2.jpg	Edgar Link	pending
img162867219_3.jpg	Edgar Link	pending
img162867219_4.jpg	Edgar Link	pending
img162867219_5.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pzg-20240630.htm	Edgar Link	pending
pzg-20240630.xsd	Edgar Link	pending
pzg-ex21_1.htm	Edgar Link	pending
pzg-ex23_1.htm	Edgar Link	pending
pzg-ex23_2.htm	Edgar Link	pending
pzg-ex23_3.htm	Edgar Link	pending
pzg-ex23_4.htm	Edgar Link	pending
pzg-ex23_5.htm	Edgar Link	pending
pzg-ex23_6.htm	Edgar Link	pending
pzg-ex23_7.htm	Edgar Link	pending
pzg-ex23_8.htm	Edgar Link	pending
pzg-ex23_9.htm	Edgar Link	pending
pzg-ex31_1.htm	Edgar Link	pending
pzg-ex31_2.htm	Edgar Link	pending
pzg-ex32_1.htm	Edgar Link	pending
pzg-ex32_2.htm	Edgar Link	pending
pzg-ex3_3.htm	Edgar Link	pending
pzg-ex4_1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pzg-20240630_htm.xml	Edgar Link	completed
pzg-ex97_1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PZG
Paramount Gold Nevada Corp Stock $pzg

2024 Q3 Form 10-K Financial Statement

#000095017024109633 Filed on September 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PZG Paramount Gold Nevada Corp Stock $pzg

2024 Q3 Form 10-K Financial Statement

#000095017024109633 Filed on September 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PZG
Paramount Gold Nevada Corp Stock $pzg